🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)

Found 125 matching trials

Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects

N/A

Premature Endothelial Dysfunction is present in patients with early rheumat...

Status

Completed

Location

Orrin M. Troum, MD and Medical Associates

Start Date

2011-12

Trial ID

NCT01499732

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

PHASE3

This randomized, double-blind, parallel group study compares the efficacy a...

Status

Completed

Location

Multiple Locations

Start Date

2010-09

Trial ID

NCT01194414

Treatments Being Tested

tocilizumab SC tocilizumab IV placebo to tocilizumab SC placebo to tocilizumab IV Disease-modifying antirheumatic drugs (DMARDs)

A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)

PHASE3

The purpose of this study is to verify the superiority of ASP015K in combin...

Status

Completed

Location

Site CN00048

Start Date

2018-09-27

Trial ID

NCT03660059

Treatments Being Tested

Peficitinib Plaebo Disease-modifying antirheumatic drugs (DMARDs)

Adherence Rate to DMARDS in Egyptian Patients With RA

N/A

The study aims at determining adherence rate to DMARDS and predicting facto...

Status

Unknown

Location

Multiple Locations

Start Date

2019-11

Trial ID

NCT03316027

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

PHASE3

This study is designed to compare the effectiveness of the experimental dru...

Status

Completed

Location

Catalina Pointe Clinical Research, Inc.

Start Date

2010-01

Trial ID

NCT01039688

Treatments Being Tested

CP-690,550 CP-690,550 Disease-modifying antirheumatic drug

A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

PHASE3

This open-label study will evaluate the efficacy and safety of tocilizumab ...

Status

Completed

Location

Aberdeen Royal Infirmary

Start Date

2014-03-04

Trial ID

NCT02046603

Treatments Being Tested

Tocilizumab DMARDs Oral Corticosteroids Methotrexate

Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)

PHASE3

This Phase 3, randomized, open-label, multicenter study in rheumatoid arthr...

Status

Terminated

Location

Multiple Locations

Start Date

2007-06

Trial ID

NCT00521924

Treatments Being Tested

infliximab DMARDs (methotrexate; chloroquine; leflunomidum; cyclosporin A; sulfasalazine; OM 89.

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

N/A

This is a secondary structured database observational study conducted in Rh...

Status

Completed

Location

Pfizer

Start Date

2022-10-10

Trial ID

NCT05572567

Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)

N/A

The purpose of this study is to find patterns in the use of non-biological ...

Status

Completed

Location

Hospital Reina Sofía

Start Date

2014-03

Trial ID

NCT02094326

A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor

PHASE2

The current study is designed to evaluate the safety and efficacy, includin...

Status

Completed

Location

Vertex Investigational Site

Start Date

2013-01

Trial ID

NCT01754935

Treatments Being Tested

VX-509 VX-509 matching placebo

Previous Next